Giant Pharmacy 365 is an authorized DME supplier for medicare equipments and products.
Giant Pharmacy 365 is a Community/Retail Pharmacy in Abingdon, Maryland. This pharmacy is owned and operated by Giant Of Maryland Llc. It is located at 3299 Emmorton Rd, Abingdon and it's customer support contact number is 410-420-3161. The authorized person of Giant Pharmacy 365 is Alison Farrell who is Director, Pharmacy Third Party of the pharmacy and his contact number is 717-240-1526. Active license number of Giant Pharmacy 365 is PO2659 for Community/Retail Pharmacy in Maryland. Giant Pharmacy 365 accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance. Giant Pharmacy 365 is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.
Pharmacy Details:
Giant Pharmacy 365 type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name:
Giant Pharmacy 365
Type:
Community/Retail Pharmacy
Location:
3299 Emmorton Rd, Abingdon, Maryland, 21009-2013
Phone:
410-420-3161
Fax:
410-420-3190
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name:
Alison Farrell
Position:
Director, Pharmacy Third Party
Contact Number:
717-240-1526
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number:
1295768547
NPI Enumeration Date:
09 Jul, 2006
NPI Last Update On:
14 Jun, 2021
Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Giant Pharmacy 365 are as mentioned below.
Specialization
License Number
State
Status
Community/Retail Pharmacy
PO2659
Maryland
Primary
Durable Medical Equipment & Medical Supplies
PO2659
Maryland
Secondary
Pharmacy
PO2659
Maryland
Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
Identifier
Type
State
Issuer
699617500
Medicaid
Maryland
2126058
Other
Other Id Number-commercial Number
Medicare Enrollment:
Giant Pharmacy 365 is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID:
Enrollment ID:
Org Name
Medicare Entity Type
7113914219
O20100930061224
Giant Of Maryland Llc
DME SUPPLIER - PHARMACY
Products Available:
Giant Pharmacy 365 has following products available for sale under medicare.
Products
Blood Glucose Monitors & Supplies: Non-mail Order
Canes & Crutches
Commodes, Urinals, & Bedpans
Diabetic Shoes & Inserts: Prefabricated
Enteral Equipment And/or Supplies
Enteral Nutrients
Ostomy Supplies
Surgical Dressings
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
1149 Harrisburg Pike, Carlisle, Pennsylvania
Zip:
17013-1607
Phone Number:
717-240-5520
Fax Number:
717-960-8371
Patients can reach Giant Pharmacy 365 at 3299 Emmorton Rd, Abingdon, Maryland or can call on customer care at 410-420-3161.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.